US Patent Family Members and Approved Drugs for Spain Patent: 2394556
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Spain Patent: ES2394556
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 9,132,239 | 2028-10-24 | insulin degludec and insulin aspart | Novo Nordisk Inc. | RYZODEG 70/30 |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
